A 70-year-old man with a history of chronic obstructive pulmonary disease (COPD), treated with inhalers, presents to his pulmonologist with worsening shortness of breath which he thinks is related to ...

Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists showed that artificial intelligence (AI) algorithms can detect signs of these clots in electrocardiograms ...

United Therapeutics Corp. (($UTHR)) announced an update on their ongoing clinical study. The MOMENTOUS Study, officially titled ‘Multi-site Study ...

Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists at the Icahn School of Medicine at Mount Sinai showed for the first time that artificial intelligence (AI) ...

Examining a patient for common or complex pulmonary issues in a primary care setting takes time and expertise — physicians need to ask about symptoms and medical history and determine which tests to ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading AI-driven health technology company and portfolio company of nference, announced a new study that revealed promising results in support of further ...

Please provide your email address to receive an email when new articles are posted on . In this cross-sectional study utilizing electrocardiography (ECG) and 2D echocardiography, Munje and colleagues ...

A numerical scoring system may be useful for diagnosing heart failure in elderly patients with stable chronic obstructive pulmonary disease (COPD) (BMJ. 2005;331:1379 ...

A Mayo Clinic and Janssen-backed venture has received FDA breakthrough designation for an algorithm designed to enable early detection of pulmonary hypertension. Anumana Inc. received the breakthrough ...

OAKLAND, Calif.--(BUSINESS WIRE)--Eko today announced Eko Telehealth, the first and only AI-powered telehealth platform for virtual cardiac and pulmonary monitoring. Being used by more than 200 health ...